drugset / Trial / NCT07547254

Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries

NCT07547254

Enrolling by invitation 60 enrolled Ruijin Hospital
NaSingle-groupOpen-labelSupportive care

Summary

To evaluate the efficacy and safety of a topical palmitoleic acid (POA) oil composition in preventing PIs and reversing Stage I damage using an integrated physiological monitoring approach.

Timeline

Start
2025-12-01
Primary completion
2026-06-01
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject palmitoleic acid Small molecule 1 ml Topical

Indications